Immunome
IMNM
#4802
Rank
NZ$3.68 B
Marketcap
NZ$31.23
Share price
-2.44%
Change (1 day)
-2.58%
Change (1 year)

Market capitalization of Immunome (IMNM)

Market cap: NZ$3.68 Billion

As of November 2026 Immunome has a market cap of NZ$3.68 Billion. This makes Immunome the world's 4802th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Immunome from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$3.68 B-10.83%
2025NZ$4.13 B254.57%
2024NZ$1.16 B61.35%
2023NZ$0.72 B1612.44%
2022NZ$42.21 M-81.61%
2021NZ$0.22 B62.34%
2020NZ$0.14 B

End of Day market cap according to different sources

On Nov 17th, 2026 the market cap of Immunome was reported to be:

NZ$3.68 Billion
by Nasdaq info icon info icon
NZ$3.68 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.51 B-59.01%๐Ÿ‡บ๐Ÿ‡ธ USA